Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Influence of Microbiota on Proteotoxicity in C. elegans Models of Alzheimer’s Disease

EF 2016-17

Résumé
Alzheimer’s disease (AD) is the most common form of dementia affecting older individuals. Alzheimer's is characterized by neurodegeneration leading to memory loss and cognitive dysfunction. Aggregation of proteins, including deposition of amyloid-? (A?) peptides in plaques, is characteristic of the disease; however, AD pathogenesis is not fully understood mechanistically. Only a small proportion of AD cases can be causally linked to a genetic alteration; thus, environmental factors likely influence the disease. Bacteria composing the human microbiota (MB) provide a potential source of mediating factors. Shifts in gut MB composition have been associated with neurologic diseases, including preliminary findings in AD. We are interested in identifying and characterizing how MB bacteria influence A? toxicity. The complexity of the MB elicits the need for a system amenable to high-throughput analysis to assess how specific bacteria influence molecular processes. Caenorhabditis elegans are a simple organism that enables such screens. Through the use of transgenic C. elegans models of AD, which express the human A? protein, I have begun screening bacteria isolated from human MB to identify those that invoke a marked effect on A?-induced toxicity. I intend to characterize both bacteria that promote or protect against A?-induced toxicity through gene expression analysis of the host. I will also create and screen mutant libraries of these bacteria to identify potential factors mediating the observed changes. The information gained from this project will not only provide greater insight into the effects of the microbiota on AD pathology, it may also reveal previously unknown factors that prove to have therapeutic benefits for AD patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367366
Name
Tench Andrea
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Influence of Microbiota on Proteotoxicity in C. elegans Models of Alzheimer’s Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid Beta; C. Elegans; Gene Environment Interactions; Microbiota; Neurodegeneration; Neuronal Health
Abstract
Alzheimer’s disease (AD) is the most common form of dementia affecting older individuals. Alzheimer's is characterized by neurodegeneration leading to memory loss and cognitive dysfunction. Aggregation of proteins, including deposition of amyloid-? (A?) peptides in plaques, is characteristic of the disease; however, AD pathogenesis is not fully understood mechanistically. Only a small proportion of AD cases can be causally linked to a genetic alteration; thus, environmental factors likely influence the disease. Bacteria composing the human microbiota (MB) provide a potential source of mediating factors. Shifts in gut MB composition have been associated with neurologic diseases, including preliminary findings in AD. We are interested in identifying and characterizing how MB bacteria influence A? toxicity. The complexity of the MB elicits the need for a system amenable to high-throughput analysis to assess how specific bacteria influence molecular processes. Caenorhabditis elegans are a simple organism that enables such screens. Through the use of transgenic C. elegans models of AD, which express the human A? protein, I have begun screening bacteria isolated from human MB to identify those that invoke a marked effect on A?-induced toxicity. I intend to characterize both bacteria that promote or protect against A?-induced toxicity through gene expression analysis of the host. I will also create and screen mutant libraries of these bacteria to identify potential factors mediating the observed changes. The information gained from this project will not only provide greater insight into the effects of the microbiota on AD pathology, it may also reveal previously unknown factors that prove to have therapeutic benefits for AD patients.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tench, Andrea
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~